Ziprasidone Hydrochloride

盐酸齐拉西酮

Report date: 2024/01/15 10:14:33
NME

Base Information

Drug NameZiprasidone Hydrochloride
Drug Alias Name佐帕司通Ziprasidona齐哌西酮ZiprasidonumZiprasidone +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsDopamine D2 receptor agonists
TargetsSerotonin 2 (5-HT2) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaPsychotic DisordersBorderline Personality Disorder +[13] 
Global Approved IndicationsSchizophreniaBipolar Disorder
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritorySweden
Original Approved Date1998/01/01
Country/TerritoryCanadaUnited StatesUkraine +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesRaqualia Pharma IncPfizer IncViatris Specialty LLC +[4] 
Inactive CompaniesViatrisDrexel University College of MedicineUniversity Medical Center Freiburg +[8] 
Active IndicationsSchizophreniaBipolar DisorderBipolar and Related Disorders
Inactive IndicationsPsychotic DisordersBorderline Personality DisorderAutistic Disorder +[10] 

Other Information

ATC CodeN05AE04
Related LinksWikipediaDrugBankKEGG